Genome Valley Hyderabad: The Complete Guide (2026)

Genome Valley is India's first organized life sciences cluster — a 2,000-acre biotech and pharmaceutical hub in Hyderabad's Medchal-Malkajgiri district that produces roughly one-third of the world's vaccine doses and hosts more than 200 companies from 18 countries. For homebuyers and investors, it also matters for a second reason: it's one of the biggest employment-driven demand engines behind North Hyderabad's residential growth, spanning Kompally, Gowdavalli, Bachupally, and Shamirpet.

This guide covers Genome Valley's history, phases, companies, master plan, connectivity, and its direct impact on real estate in the surrounding corridor.

Genome Valley at a Glance

What Is Genome Valley?

Genome Valley is India's first organized cluster for life sciences R&D and clean manufacturing, centered around Shamirpet in Hyderabad's Medchal-Malkajgiri district, roughly 30-35 km north of central Hyderabad. It brings together industrial parks, knowledge parks, Special Economic Zones (SEZs), multi-tenanted laboratories, and incubation facilities under a single administrative umbrella.

In FY 2017-18, the Telangana government granted Genome Valley Industrial Area Local Authority (IALA) status, giving companies within the cluster single-point access to government approvals and infrastructure support rather than navigating multiple departments separately. Today it is home to more than 200 companies from 18 countries, spanning vaccine manufacturing, pharmaceutical R&D, biologics, agri-biotech, and clinical research.

Genome Valley: History & Origins

Genome Valley was established in 1999 as S.P. Biotech Park, a public-private partnership between Bharat Biotech International — founded by Dr. Krishna Ella — and private infrastructure partners including the Shapoorji Pallonji Group and ICICI Bank. In 2001, following the National Biotechnology Policy, the undivided Andhra Pradesh government formally designated land across the Ranga Reddy and Medak districts for the cluster, which has since grown to its current 2,000-acre footprint.

VMR Buildcon's Director, Shashidhar Kanukolanu, brings direct institutional insight into this history: he served as Chief Financial Officer with the Shapoorji Pallonji Group during the period the group was investing in Genome Valley's founding infrastructure — one of the reasons VMR pays close attention to how this corridor continues to develop.

Over the following two decades, the cluster attracted global names including Novartis, GlaxoSmithKline, and Merck, alongside India's largest vaccine manufacturers, cementing Hyderabad's identity as the country's life sciences capital.

Genome Valley Location: Phases & Layout

Genome Valley is organized into three development phases. Phase I and Phase II are concentrated around Shamirpet and Turkapally, close to the Hyderabad Outer Ring Road. Phase III sits roughly 11 km further out, at Karkapatla, with additional land — the Telangana government cites approximately 120 acres — available for industrial allotment.

Within the cluster, sub-parks operate under different ownership models, including the IKP Knowledge Park (a 200-acre ICICI Bank initiative in Turkapally) and Neovantage Innovation Parks (formerly MN Park, originally developed by U.S.-based Alexandria Real Estate Equities), which together provide over a million square feet of Grade-A lab and R&D space to tenants like Novartis, GSK, and Mylan.

Genome Valley 2.0: The Master Plan Explained

Genome Valley 2.0 is the Telangana government's master plan, launched in 2018, to evolve the cluster from a pure manufacturing zone into what the state's Regional Master Plan describes as an integrated, self-sufficient life sciences city. The plan was developed with Jurong Consultants India, part of Singapore's Surbana Jurong group, and rests on four pillars:

• An Integrated & Connected City — transit-oriented development linking Genome Valley seamlessly to Hyderabad city

• An Innovative & Vibrant Economic City — economic diversification and expanded employment opportunities

• A Liveable & Self-Sustained City — residential districts with amenities within walking distance, letting people live closer to where they work

• An Ecologically Sustained & Enriched City — conservation of environmentally sensitive areas surrounding the cluster

That third pillar matters more than it might seem at first glance: it's the state government explicitly building residential development into Genome Valley's official master plan — not incidental sprawl, but a planned response to a cluster that already employs tens of thousands of people with limited housing close by.

Genome Valley Companies: Who Operates Here

Genome Valley hosts more than 200 companies from 18 countries, spanning the full life sciences value chain — from vaccine manufacturing and global pharma R&D to contract research and specialized institutes.

• Vaccine manufacturing — Bharat Biotech, Biological E, and Indian Immunologicals, three of India's largest vaccine producers, all operate here.

• Global pharma & biotech — Novartis, GlaxoSmithKline, Sandoz, Mylan (Viatris), Ferring Pharma, Merck, DuPont, Ashland, and Lonza maintain R&D or manufacturing operations in the cluster.

• Contract research & manufacturing (CRO/CDMO) — Syngene International, Sai Life Sciences, Aurigene, and Cohance support global clients with drug discovery and development services.

• Research institutions — L.V. Prasad Eye Institute and the National Academy of Agricultural Research Management operate alongside the commercial tenants.

Quick-reference list of notable Genome Valley companies by category:

Genome Valley Companies: Recent Developments (2022-2026)

Genome Valley's expansion has accelerated since 2022, with several large investments announced or completed:

• Hetero Drugs — a Rs. 750 crore sterile pharmaceutical manufacturing unit, announced in 2022.

• Granules India — scaling finished-dosage manufacturing capacity toward 8 billion units per year by 2026.

• Yapan Bio (Piramal-backed) — a dedicated biologics process development facility supporting RNA, DNA, and viral vector products.

These additions signal that Genome Valley's growth is accelerating rather than plateauing, which matters directly for the pace of housing demand in the surrounding corridor.

Genome Valley's Economic & Manufacturing Impact

Genome Valley produces more than 11 billion vaccine doses annually as of mid-2025 — around one-third of the world's total vaccine supply — with Bharat Biotech and Biological E responsible for most of that output. The wider Hyderabad pharma ecosystem anchored by Genome Valley accounts for approximately 35% of India's pharmaceutical and bulk drug production.

Estimates of Genome Valley's direct workforce vary by source and year. Official Telangana government figures put it at around 15,000 scientific professionals, while more recent 2025 statements from Telangana Life Sciences leadership cite a figure closer to 25,000 employees across the cluster. Either way, it represents a large, high-income, and steadily growing workforce concentrated in one part of the city — precisely the population driving housing demand in the surrounding corridor.

Genome Valley Connectivity: How It Links to North Hyderabad

Genome Valley connects to North Hyderabad primarily through Exit 7 of the Hyderabad Outer Ring Road (ORR) — the Shamirpet exit — which feeds directly onto NH 44 and the wider Kompally-Medchal-Shamirpet corridor. This is the single most important connectivity fact for anyone evaluating real estate near the cluster: you don't need to enter congested inner-city roads to reach it from most of North Hyderabad.

From Gowdavalli, Genome Valley is approximately 15 km away via NH 44 — making it one of the closer established residential zones to this employment cluster. The same ORR-NH 44 backbone also serves Kompally, Bachupally, and the wider Malkajgiri corridor. Looking further ahead, the upcoming Regional Ring Road (RRR) — a 340 km expressway under the Bharatmala Pariyojana program — is set to intersect NH 44 in this same Kompally-Medchal-Shamirpet belt. Industry watchers frequently compare its likely long-term effect to what the ORR did for Gachibowli and HITEC City in the mid-2000s, playing out over a longer timeframe in the north.

What's Near Genome Valley: Landmarks & Amenities

Genome Valley's Shamirpet location places it close to several well-known North Hyderabad landmarks and institutions, which matter to the professionals who work there and, by extension, to the residential areas serving them:

• BITS Pilani Hyderabad Campus — a well-regarded higher-education institution near the Shamirpet ORR exit.

• Shamirpet Lake — a recreational landmark adjacent to the cluster.

• Leonia Holistic Destination — a large resort and convention property in the immediate vicinity.

Genome Valley vs. Hyderabad Pharma City: Key Differences

Genome Valley and Hyderabad Pharma City are two separate projects that are frequently confused with each other. Hyderabad Pharma City (recently rebranded Green Pharma City) spans roughly 19,000 acres near Mucherla village in Ranga Reddy district, about 50 km south of Hyderabad — a different location, scale, and governance structure from Genome Valley, the established life sciences cluster in Shamirpet and the Medchal-Malkajgiri district covered in this guide. If you're researching real estate near either project, make sure you're looking at the right map.

Genome Valley's Impact on North Hyderabad Real Estate

Genome Valley's workforce and its government-backed master plan are directly fueling residential demand across North Hyderabad. A cluster employing 15,000-25,000+ qualified professionals, backed by a master plan that formally includes residential development, creates structural — not speculative — housing demand in the surrounding corridor. That demand doesn't stay confined to Shamirpet itself; it radiates outward along NH 44 and the ORR into Kompally, Gowdavalli, Bachupally, and Malkajgiri, where land and construction costs remain considerably lower than in Hyderabad's western IT corridor.

VMR Buildcon has built its own presence in this corridor around that thesis. In Malkajgiri, VMR is the turnkey construction contractor for SAI NEST (RERA Reg. No. P02200010954), a 40-unit residential project currently under construction. VMR Buildcon's upcoming project in Gowdavalli near Kompally is positioned to serve exactly this kind of Genome Valley-adjacent demand.

Genome Valley: Key Takeaways for Homebuyers

• Genome Valley employs 15,000-25,000+ high-income professionals in a corridor with limited nearby housing supply.

• Genome Valley 2.0's master plan formally includes residential development — a state-level signal, not developer speculation.

• The Shamirpet ORR exit and NH 44 connect the cluster directly to Kompally, Gowdavalli, Bachupally, and Malkajgiri.

• The upcoming Regional Ring Road (RRR) is expected to further strengthen this corridor's connectivity from 2028 onward.

Genome Valley isn't just a biotech landmark — it's one of the clearest, most durable demand drivers behind North Hyderabad's residential growth story. For homebuyers and investors evaluating this corridor, understanding what's actually happening inside the cluster matters as much as understanding the property itself.